Outpatient Service for Mid-trimester Termination of Pregnancy

PHASE4CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Abortion in Second Trimester
Interventions
DRUG

Mifepristone + Misoprostol

A single dose of 200 mg mifepristone (one tablet) to be taken orally either at home or at the hospital, followed 24-48 hours later with 400mcg misoprostol (buccal) at home. The participant will return to the hospital one to two hours after taking the initial dose of misoprostol to receive repeated doses of 400 mcg misoprostol until the abortion occurs.

Trial Locations (3)

Unknown

KIST Medical College, Teaching Hospital, Imadol

Kathmandu Medical College, Kathmandu

Kathmandu Model Hospital, Kathmandu

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CREHPA

UNKNOWN

collaborator

Kathmandu Medical College and Teaching Hospital

OTHER

collaborator

Kathmandu Model Hospital

UNKNOWN

collaborator

KIST Medical College

UNKNOWN

lead

Gynuity Health Projects

OTHER

NCT03346629 - Outpatient Service for Mid-trimester Termination of Pregnancy | Biotech Hunter | Biotech Hunter